Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 16.85
-0.15 (-0.88%)
At close: Jul 31, 2026
Xlife Sciences AG Financials Overview
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 0.28 | 0.28 | 0.83 | 0.99 | 1.03 | 0.81 |
Revenue Growth | -67.20% | -67.02% | -15.53% | -3.85% | 27.53% | 103.14% |
Gross Profit Gross Profit Growth | 0.01 | 0.01 | 0.55 | 0.45 | 0.19 | 0.36 |
Operating Income Operating Income Growth | -31.56 | -31.56 | -19.35 | -20.31 | -20.98 | -5.23 |
Net Income Net Income Growth | -21.55 | -21.55 | 34.28 | 14.88 | 14.31 | 53.42 |
Earnings Per Share EPS Growth | -3.76 | -3.76 | 4.54 | 2.08 | 2.00 | 8.66 |
EPS Growth | - | - | 118.26% | 4.15% | -76.95% | 136.46% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Technology Platforms Technology Platforms Growth | 0.15 | 0.15 | 0.15 | - | - | - |
Unallocated Unallocated Growth | 0.13 | 0.13 | 0.68 | 0.65 | 0.75 | 0.71 |
Total Total Growth | 0.28 | 0.28 | 0.83 | 0.99 | 1.03 | 0.82 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1.05 | 1.05 | 0.1 | 0.22 | 0.22 | 1.96 |
Total Debt Total Debt Growth | 60.57 | 60.57 | 59.32 | 56.7 | 60.63 | 63.47 |
Net Cash (Debt) Net Cash Growth | -59.52 | -59.52 | -59.22 | -56.48 | -60.41 | -61.51 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -10.38 | -10.38 | -8.07 | -7.80 | -8.33 | -9.94 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.9 | -0.9 | -0.42 | 0.17 | -4.61 | -4.32 |
Capital Expenditures CapEx Growth | -0.37 | -0.37 | -0.01 | -0.01 | -0.02 | -0.16 |
Free Cash Flow Free Cash Flow Growth | -1.28 | -1.28 | -0.43 | 0.16 | -4.62 | -4.48 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 3.38% | 3.38% | 65.82% | 45.43% | 18.06% | 44.55% |
Operating Margin | -11462.04% | -11462.04% | -2317.30% | -2054.30% | -2041.02% | -649.21% |
Pretax Margin | -11572.28% | -11572.28% | 2870.75% | 458.70% | 392.91% | 6599.31% |
Profit Margin | -7826.51% | -7826.51% | 4105.62% | 1505.34% | 1392.26% | 6627.06% |
FCF Margin | -463.19% | -463.19% | -51.94% | 15.97% | -449.70% | -555.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 4.26 | 18.75 | 10.97 | - |
P/FCF Ratio | - | - | - | 1766.87 | - | - |
PS Ratio | 349.00 | 517.45 | 174.69 | 282.22 | 152.66 | - |